| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $23.8M | +31.8% |
| SG&A Expense | $11.9M | -18.7% |
| Operating Income | -$35.7M | +9.8% |
| Interest Expense | $1.1M | -70.6% |
| Income Tax | $0 | -100.0% |
| Net Income | -$35.2M | +9.3% |
| EPS (Basic) | -$6.96 | -439.5% |
| EPS (Diluted) | -$6.96 | -439.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | -74.5% |
| Current Assets | $16.3M | -68.2% |
| Total Assets | $27.1M | -48.6% |
| Current Liabilities | $9.8M | +53.3% |
| Total Liabilities | $15.8M | +74.9% |
| Stockholders' Equity | $11.4M | -74.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.7M | +14.8% |
| Capital Expenditures | $66K | — |
| Investing Cash Flow | -$32K | — |
| Financing Cash Flow | $38.6M | — |
| Free Cash Flow | -$32.8M | +14.7% |